- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428204
Effect of Inflation on the Angiographic Result After Balloon Angioplasty in the Femoropopliteal Segment (Balloon-angio)
Effect of Different Inflation Times on the Angiographic Result After Balloon Angioplasty in the Femoropopliteal Segment: a Prospective Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1200
- Recruiting
- Cliniques Universitaires Saint-luc
-
Contact:
- Parla Astarci, MD, PhD
- Phone Number: 6107 0032 2 764
- Email: parla.astarci@uclouvain.be
-
Contact:
- Maxime Elens, MD
- Phone Number: 8063 0032 2 764
- Email: maxime.elens@uclouvain.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with symptomatic atherosclerotic stenotic lesions of the femoropopliteal artery suitable for angioplasty in the adult population
Exclusion Criteria:
- Artery lesions shorter than 1 cm and longer than 10 cm length, total occlusions, severe calcification, previous angioplasty with current restenosis, previous stenting with current insistent restenosis and subintimal recanalization of the lesion
- No pregnant and nursing women will be included.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: 180 seconds balloon dilation
Percutaneous angioplasty with balloon dilation during 180 seconds for percutaneous treatment of femoropopliteal artery stenosis
|
Percutaneous angioplasty with balloon dilation during 180 seconds as a method for percutaneous treatment of femoropopliteal artery lesions
Other Names:
|
|
Other: 300 seconds balloon dilation
Percutaneous angioplasty with balloon dilation during 300 seconds for percutaneous treatment of femoropopliteal artery stenosis
|
Percutaneous angioplasty with balloon dilation during 300 seconds as a method for percutaneous treatment of femoropopliteal artery lesions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of residual stenosis between both groups
Time Frame: at 3 or 5 minutes
|
The primary outcome of the study is to assess the difference in number of residual stenosis after balloon dilatation of the arterial lesion between both groups (3min and 5min). A residual stenosis (measured on the angiogram) responsible for an arterial stenosis of >30% will be defined as unsuccessful treatment. The group with the lowest number of arterial restenosis >30% after dilatation has the best primary outcome. |
at 3 or 5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of redilatation or additional stenting between both groups
Time Frame: at 3 or 5 minutes
|
The secondary outcome of the study is to evaluate the difference in need of redilatation or provisional stenting after the first dilatation between both groups (3 vs 5min).
If an arterial stenosis of >30% after dilatation is measured, a redilatation of an additional stenting will be placed.
The group with the lowest number of redilatation or additional stenting after dilatation has the best secondary outcome.
|
at 3 or 5 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Parla Astarci, MD, PhD, Cliniques Universitaires Saint-luc
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2017/17AOU/406
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoropopliteal Arterial Stenosis
-
Paracelsus Medical UniversityMedAlliance Swiss Medical TechnologyWithdrawnPeripheral Arterial Occlusive Disease | Claudication, Intermittent | Bypass Complication | Femoropopliteal Artery Occlusion | Femoropopliteal Stenosis | Critical Limb-Threatening IschemiaAustria
-
C. R. BardCompletedPeripheral Artery Disease | Femoropopliteal Artery Occlusion | Femoropopliteal StenosisUnited States
-
Paracelsus Medical UniversityRecruitingPeripheral Arterial Occlusive Disease | Claudication, Intermittent | Femoropopliteal Artery Occlusion | Femoropopliteal Stenosis | Critical Limb-Threatening IschemiaAustria
-
Centre hospitalier de l'Université de Montréal...Abbott Medical Devices; Centre de Recherche du Centre Hospitalier de l'Université... and other collaboratorsWithdrawnFemoropopliteal StenosisCanada
-
Rijnstate HospitalAbbott; University of TwenteActive, not recruitingFemoropopliteal StenosisNetherlands
-
Cordis CorporationFCRE (Foundation for Cardiovascular Research and Education)CompletedPeripheral Arterial Disease | Femoropopliteal Stenosis | Angiopathy, PeripheralAustria, Netherlands, France
-
University Hospital, Strasbourg, FranceRecruitingPeripheral Artery Disease | Femoropopliteal StenosisFrance
-
Efemoral Medical, Inc.RecruitingVascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal StenosisAustralia, New Zealand
-
Abbott Medical DevicesTerminatedPeripheral Vascular Disease | Peripheral Artery Disease | Femoropopliteal Artery StenosisGermany
-
Assiut UniversityNot yet recruitingFemoropopliteal Occlusive DiseaseEgypt
Clinical Trials on Balloon dilation during 180 seconds
-
Samuel H MardiniWithdrawn
-
Lund UniversitySkane University HospitalActive, not recruitingAsphyxia Neonatorum | ResuscitationSweden
-
The Second Affiliated Hospital of Chongqing Medical...West China Hospital; Qianjiang Hospital, Chongqing UniversityRecruitingLiver Cirrhosis | Ascites Hepatic | Variceal Bleeding, Cirrhosis | Hepatic Encephalopathy (HE)China
-
RenJi HospitalUnknown
-
Entellus Medical, Inc.CompletedChronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)United States
-
Nanjing First Hospital, Nanjing Medical UniversityBrosMed Medical Co., LtdCompletedCoronary Artery DiseaseChina
-
Shenzhen People's HospitalNot yet recruitingde Novo Coronary Lesions
-
Centre hospitalier de l'Université de Montréal...CompletedEsophageal CancerCanada
-
National Taiwan University HospitalUnknown
-
Entellus Medical, Inc.North American Science Associates Ltd.Completed